Studies have implicated soluble epoxide hydrolase (sEH) in many disorders of the central nervous system, including Parkinson’s disease, white matter hyperintensities, vascular cognitive decline/impairment, and Alzheimer’s disease [22,23,24,25,26]. This evidence concerns the gene EPHX2 and Parkinson disease.